Globestar Therapeutics (GSTC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GSTC Annual Balance Sheets →
Examining balance sheet movements between Globestar Therapeutics and Jun 30 2023 reveals how Jun 30 2024 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.08
Total Current Assets0.08
Other Assets, Noncurrent0.00
Total Assets0.08
Liabilities
Accounts Payable1.16
Interest Payable, Current IN0.22
Short-term Debt0.03
Other Liabilities, Current0.30
Total Current Liabilities1.71
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Related Party Advances0.00
Convertible Note Payable Current-
Total Liabilities1.71
Stockholders' Equity
Common Stock Value1.24
Additional Paid In Capital Common Stock17.98
Retained Earnings / Accumulated Deficit-21.02
Other Equity0.18
Common Stockholder's Equity-1.62
Total Stockholder's Equity-1.62
Liabilities & Stockholder's Equity0.08
4 historic quarters locked

Sign in to unlock the full Globestar Therapeutics balance sheet history.

About Globestar Therapeutics Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240630)
  • Filed with the SEC: October 11, 2024
  • Source: form_10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001161697-24-000420

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License